Exhibit 1001 Description U.S. Patent No. 8,530,171 B2, issued September 10, 2013 1002 1003 1004 1005 1006 1007 1008 1009 File History for U.S. Patent No. 8,530,171 B2 Declaration of R. John Collier WO 2011/042516, published April 14, 2011 (“Blais”) Charles H. Squires et al., Heterologous Protein Production in P. fluorescens, BIOPROCESS INTERNATIONAL 2(11):54-59 (2004) (“Squires”) J. H. Choi et al., Efficient secretory production of alkaline phosphatase by high cell density culture of recombinant Escherichia coli using the Bacillus sp.
53:640-645 (2000) (“Choi”) U.S. Patent Application Publication No. 2008/0269070 to Ramseier et al., published October 30, 2008 (“Ramseier I”) U.S. Patent Application Publication No. 2006/0110747 to Ramseier et al., published May 25, 2006 (“Ramseier II”) Bláithín Maunsell et al., Complex regulation of AprA metalloprotease in Pseudomonas fluorescens M114: evidence for the involvement of iron, the ECF sigma factor, PbrA and pseudobactin M114 siderophore, MICROBOLOGY 152:29-42 (2006) (“Maunsell”) 1010 A. M. Pappenheimer, Jr., Diphtheria Toxin, ANN.
Patent No. 8,530,171 Description Donald O. O’Keefe & R. John Collier, Cloned diphtheria toxin within the periplasm of Escherichia coli causes lethal membrane damage at low pH, PROC.
Markus Eser et al., Disulfide bond formation by exported glutaredoxin indicates glutathione’s presence in the E. coli periplasm, PNAS 106(5):1572-1577 (2009) George Georgiou & Laura Segatori, Preparative expression of secreted proteins in bacteria: status report and future prospects,
Michael G. Jobling et al., Construction and Characterization of Versatile Cloning Vectors for Efficient Delivery of Native Foreign Proteins to the Periplasm of Escherichia coli,